Beyond Observation: Validating the Ecological Relevance of the Ad-AHA Stroke Using Sensor-Based Measures
1 other identifier
observational
32
1 country
1
Brief Summary
After a stroke, many people experience difficulty using both hands together in daily life. Most rehabilitation assessments, however, only measure how the affected arm performs in one-handed tasks. This makes it difficult to understand how well people actually use their hands in real-world activities, which are usually bimanual. The Adult Assisting Hand Assessment - Stroke version (Ad-AHA Stroke) is a new clinical test that evaluates how the affected hand performs during two-handed tasks. While promising, it is still unknown whether the score on this test truly reflects how stroke survivors use their hands in daily life. This study aims to investigate this question by comparing Ad-AHA Stroke scores with real-life data on hand use, recorded over three days using wrist-worn sensors on both arms. By combining clinical and sensor-based measures, this study will help determine whether the Ad-AHA Stroke can accurately represent everyday bimanual performance after stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2025
CompletedFirst Submitted
Initial submission to the registry
January 8, 2026
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedJanuary 26, 2026
January 1, 2026
6 months
January 8, 2026
January 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between Ad-AHA Stroke total score and accelerometer-derived Use Ratio
The primary endpoint is the strength of association between the Ad-AHA Stroke total score, obtained during the measurement visit, and real-world bimanual upper limb use, quantified by the accelerometer-derived Use Ratio calculated from the subsequent 3-day home monitoring period. The Use Ratio is calculated as the total duration of activity of the affected limb divided by that of the non-affected limb (range 0-1, with 1 indicating equal use of both limbs). This measure reflects spontaneous bimanual activity balance and serves as the primary indicator of the ecological validity of the Ad-AHA Stroke.
Baseline (measurement visit), including a continuous 72-hour wrist accelerometer monitoring period
Secondary Outcomes (1)
Correlation between Ad-AHA Stroke score and composite accelerometer index
Baseline (measurement visit), including a continuous 72-hour wrist accelerometer monitoring period
Other Outcomes (1)
Correlations between Ad-AHA Stroke score and individual accelerometry-derived features
Baseline (measurement visit), including a continuous 72-hour wrist accelerometer monitoring period
Interventions
Participants will complete the Ad-AHA Stroke assessment and wear bilateral wrist accelerometers for 3 days to measure real-life bimanual activity. No treatment or experimental intervention will be administered.
Eligibility Criteria
Study participants will be adults with chronic stroke (≥ 6 months post-onset) who have observable difficulties in performing bimanual tasks. Participants will be recruited from KU Leuven's rehabilitation network, including university-affiliated rehabilitation centers and outpatient clinics in the Leuven region. All participants will be community-dwelling and medically stable at the time of inclusion.
You may qualify if:
- Written informed consent obtained prior to any study procedures.
- Age between 18 and 80 years (inclusive).
- Unilateral supratentorial stroke involving cortical or subcortical structures.
- Community-dwelling (discharged from hospital and currently living at home).
- Able and willing to wear bilateral wrist-worn sensors (triaxial accelerometers) for three consecutive days.
- Presence of clinically observable bimanual impairment.
You may not qualify if:
- Severe upper limb impairment, defined as a Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score ≤ 15.
- Severe cognitive or language comprehension impairment interfering with understanding of study instructions or task performance, as judged during screening.
- Presence of other neurological or orthopedic conditions affecting upper limb function (e.g., Parkinson's disease, multiple sclerosis, severe osteoarthritis, brachial plexus injury).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
Department of Rehabilitation Sciences, KU Leuven
Leuven, 3000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geert Verheyden
KU Leuven
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Rehabilitation Sciences
Study Record Dates
First Submitted
January 8, 2026
First Posted
January 26, 2026
Study Start
December 10, 2025
Primary Completion
June 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
January 26, 2026
Record last verified: 2026-01